The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


22 Jul 2021

Sino-Australia COVID-19 Seminar Series part three: SARS-CoV-2 virology

Add to my calendar 22/07/2021 9:57 am Australia/Melbourne Sino-Australia COVID-19 Seminar Series part three: SARS-CoV-2 virology Online DD/MM/YYYY

22 Jul 2021
2.00 - 3.00pm


Please join the collaborative webinar hosted by Professor Kanta Subbarao, Director of the WHO Collaborating Centre for Reference and Research on Influenza, with a welcome from Professor Sharon Lewin, Doherty Institute Director and three data driven presentations on COVID-19 Virology

Attend the webinar: 

Professor Linqi Zhang - Tsinghua University

Professor Zhang is the Director of the Comprehensive AIDS Research Center at Tsinghua University. Prof. Zhang's research focuses on HIV-1 pathogenesis and vaccine development, and has recently expanded to cover emerging and re-emerging human viral pathogens, such as SARS-CoV-1/2 and MERS-CoV. Using cutting-edge antibody and antigen library techniques, Prof. Zhang aims to characterize protective antibody immunity and explore rational design of effective vaccines and therapies against viral infections.

Dr Runhong Zhou - The University of Hong Kong

Dr Zhou obtained his PhD from Wuhan University then completed his postdoctoral training in the laboratory of Dr. Zhiwei Chen at the University of Hong Kong. His primary research interest is the molecular mechanisms underlying the regulation of dendritic cells (DC) during HIV infection. He is investigating a DC-based vaccine for HIV functional cure. Since the COVID-19 pandemic, he has investigated the role of host immune responses in acute SARS-CoV-2 infection. Dr Wei Zhao – The Doherty Institute 

DrWei Zhao - Doherty Institute 

Dr Wei Zhao is a postdoctoral research fellow in Professor Sharon Lewin's laboratory at the Doherty Institute, Australia. His main research interest is in vitro study of HIV and HBV co-infection in the hepatocytes. He is also leading projects on COVID-19 using novel strategies to inhibit SARS-CoV-2 replication.

This seminar series is proudly supported by the National Foundation for Australia-China Relations